Longeveron, Inc. (LGVN)
2.48
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 09:56
Longeveron Price : 2.48 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 2.40 | 2.60 | 2.34 | 2.48 | 58460.00 |
| Oct 08, 2026 | 2.45 | 2.57 | 2.32 | 2.37 | 77298.00 |
| Oct 07, 2026 | 2.33 | 2.48 | 2.33 | 2.44 | 58117.00 |
| Oct 06, 2026 | 2.50 | 2.50 | 2.340 | 2.35 | 83785.00 |
| Oct 05, 2026 | 2.59 | 2.692 | 2.51 | 2.51 | 44156.00 |
| Oct 02, 2026 | 2.56 | 2.675 | 2.54 | 2.58 | 20808.00 |
| Oct 01, 2026 | 2.72 | 2.74 | 2.52 | 2.59 | 72955.00 |
| Sep 30, 2026 | 2.73 | 2.80 | 2.61 | 2.69 | 54970.00 |
| Sep 29, 2026 | 2.68 | 2.74 | 2.604 | 2.72 | 55196.00 |
| Sep 28, 2026 | 2.79 | 2.79 | 2.622 | 2.63 | 102034.0 |
| Sep 25, 2026 | 2.89 | 2.95 | 2.76 | 2.81 | 50529.00 |
| Sep 24, 2026 | 2.54 | 2.97 | 2.50 | 2.91 | 172837.0 |
| Sep 23, 2026 | 2.68 | 2.760 | 2.53 | 2.60 | 62312.00 |
| Sep 22, 2026 | 2.47 | 2.83 | 2.32 | 2.72 | 233992.0 |
| Sep 21, 2026 | 2.49 | 2.54 | 2.33 | 2.45 | 171725.0 |
| Sep 18, 2026 | 2.80 | 2.80 | 2.300 | 2.49 | 527170.0 |
| Sep 17, 2026 | 3.23 | 3.35 | 2.70 | 2.71 | 1.443M |
| Sep 16, 2026 | 6.83 | 7.15 | 6.52 | 6.68 | 316645.0 |
| Sep 15, 2026 | 6.89 | 7.10 | 6.65 | 6.86 | 44377.00 |
| Sep 14, 2026 | 7.195 | 7.60 | 6.92 | 6.92 | 61879.00 |
| Sep 11, 2026 | 6.79 | 7.360 | 6.64 | 7.33 | 68153.00 |
| Sep 10, 2026 | 6.52 | 6.800 | 6.50 | 6.64 | 59566.00 |
| Sep 09, 2026 | 6.58 | 6.75 | 6.51 | 6.58 | 29569.00 |
| Sep 08, 2026 | 6.78 | 6.90 | 6.56 | 6.65 | 50155.00 |
| Sep 04, 2026 | 6.54 | 6.88 | 6.53 | 6.81 | 41237.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 62.14 |
| Oncolytics Biotech, Inc. | 0.5403 |
| Sangamo Therapeutics, Inc. | 0.1478 |
| Sarepta Therapeutics, Inc. | 18.05 |
| Anixa Biosciences, Inc. | 2.90 |
Price Related Metrics
| PS Ratio | 5.091 |
| Price to Book Value | 0.7562 |
| Earnings Yield | -409.3% |
| Market Cap | 7.866M |